Some of the cellular targets, such as insulin, glutamic acid decarboxylase, tyrosine phosphatase-related insulinoma-associated 2 molecules, and zinc transporter-8 [3,63] whose autoantibodies have been identified in many T1DM patients, might be the potential targets for covalent modifications by STZ. Here, INS is linked to type 1 diabetes mellitus.